MoxiSolv - MWI VetOne | Bimeda, Inc.

Manufacturer
MWI VetOne | Bimeda, Inc.
Effective date
2026-08-20
Label type
OTC ANIMAL DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-08-25 01:01:43

Label at a glance#

ProductMoxiSolv
Active ingredientMOXIDECTIN
Label structure16 sections

Storage and handling

Storage: Store at or below 25°C (77°F). Excursions to 40°C (104°F) are permitted. If product becomes frozen, thaw completely and shake well prior to use. Disposal: Dispose of containers in an approved landfill or by incineration.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

MoxiSolv™ Pour-On
(moxidectin)

Pour-On for Beef and Dairy Cattle

Antiparasitic

Contains 5 mg moxidectin/mL

For Treatment of Infections and Infestations Due to Internal and External Parasites of Beef and Dairy Cattle

Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. If animals are likely to be reinfected following treatment, a strategic parasite control program should be established.

MECHANISM OF ACTION SECTION

Mode of Action: Moxidectin is an endectocide in the milbemycin chemical class which shares the distinctive mode of action characteristic of macrocyclic lactones. MoxiSolv Pour-On (moxidectin) is specially formulated to allow moxidectin to be absorbed through the skin and distributed internally to the areas of the body affected by endo- and/or ectoparasitism. Moxidectin binds selectively and with high affinity to glutamate-gated chloride ion channels which are critical to the function of invertebrate nerve and muscle cells. This interferes with neurotransmission resulting in paralysis and elimination of the parasite.

INDICATIONS & USAGE SECTION

Indications: MoxiSolv Pour-On when applied at the recommended dose level of 0.5 mg/2.2 lb (0.5 mg/kg) body weight is effective in the treatment and control of the following internal [adult and fourth-stage larvae (L4)] and external parasites of cattle:

Gastrointestinal Roundworms
Ostertagia ostertagi - Adult and L4 (including inhibited larvae)
Haemonchus placei - Adult and L4
Trichostrongylus axei - Adult and L4
Trichostrongylus colubriformis - Adult and L4
Cooperia oncophora - Adult and L4
Cooperia pectinata - Adult
Cooperia punctata - Adult and L4
Cooperia spatulata – Adult
Cooperia surnabada - Adult and L4
Bunostomum phlebotomum - Adult
Nematodirus helvetianus - Adult and L4
Oesophagostomum radiatu m - Adult and L4

Lungworms
Dictyocaulus viviparus - Adult and L4

Cattle Grubs
Hypoderma bovis
Hypoderma lineatum

Mites
Chorioptes bovis
Psoroptes ovis (Psoroptes communis var. bovis)

Lice
Linognathus vituli
Haematopinus eurysternus
Solenopotes capillatus
Bovicola (Damalinia) bovis

Horn Flies
Haematobia irritans

SPL UNCLASSIFIED SECTION

Management Considerations for External Parasites: For most effective external parasite control, MoxiSolv Pour-On should be applied to all cattle in the herd. Cattle entering the herd following this administration should be treated prior to introduction. Consult your veterinarian or a livestock entomologist for the most appropriate time to apply MoxiSolv Pour-On in your location to effectively control horn flies and external parasites. MoxiSolv Pour-On provides seven days of persistent activity against horn flies. For optimal control of horn flies, the product should be used as part of an integrated control program utilizing other methods to provide extended control.

SPL UNCLASSIFIED SECTION

Persistent Activity: Moxidectin pour-on has been proven to effectively control infections and protect from reinfection with Haemonchus placei for 14 days after treatment, Oesophagostomum radiatum and Ostertagia ostertagi for 28 days after treatment, and Dictyocaulus viviparus for 42 days after treatment. Efficacy below 90% was observed in some Ostertagia ostertagi persistent activity studies at 21 and 28 days posttreatment.

DOSAGE & ADMINISTRATION SECTION

Dosage: MoxiSolv Pour-On (moxidectin) is a ready-to-use topical formulation intended for direct application to the hair and skin in a narrow strip extending along the top of the back from the withers to the tailhead (see Figure 1). Due to the angular topline characteristic of most dairy breeds, it is recommended that all pour on products be applied slowly to dairy cows. Apply to healthy skin avoiding any mange scabs, skin lesions, mud or manure. Treated cattle can be easily recognized by the characteristic purple color, which will remain for a short period of time after treatment. The recommended rate of administration is 1 mL for each 22 lb (10 kg) body weight which provides 0.5 mg moxidectin for each 2.2 lb (0.5 mg/kg) body weight. The table below will assist in the calculation of the appropriate volume of pour-on which must be applied based on the weight of animal being treated.

Figure 1Figure 1

Figure 1. Where to Apply MoxiSolv Pour-On

TablesTables

  • Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

Use Conditions: Varying weather conditions, including rainfall, do not affect the efficacy of MoxiSolv Pour-On.

Administration: MoxiSolv Pour-On is available in two convenient package styles designed for ease of administration and the number of cattle to be treated. Directions for use of each container type follow:
Large Conventional Containers (169 fl oz/5 L Bottles and 338 fl oz/10 L Cubetainer)

These bottles are designed for use with most commercially-available applicators. Simply remove the transient cap and seal and replace with the vented cap. Attach the applicator feeder hose to the vented cap. Invert the container prior to use (5 L containers only). Apply the recommended volume of MoxiSolv Pour-On evenly along the backline of the animal from the withers to the tailhead (see Figure 1).

Figure 2Figure 2

Figure 3Figure 3

ANIMAL PHARMACOLOGY & OR TOXICOLOGY SECTION

Animal Safety: Tolerance and toxicity studies have demonstrated an adequate margin of safety to allow treatment of cattle of all ages with moxidectin pour-on. No toxic signs were seen in cattle given up to 25 times the recommended dose level. Newborn calves similarly showed no toxic signs when treated with up to three times the recommended dose level within 12 hours of birth and nursing from cows concurrently treated with the recommended dose level of moxidectin pour-on. In breeding animals (bulls and cows in estrous and during early, mid and late pregnancy), treatment with three times the recommended dose level had no effect on breeding performance.

WARNINGS SECTION

Warning: Not For Use In Humans. Keep this and all drugs out of the reach of children. This product can cause irritation to skin, eyes, or mucous membranes. In case of accidental skin contact and/or clothing contamination, wash skin thoroughly with soap and water and launder clothing with detergent. In case of accidental eye contact, flush eyes with copious amounts of water. When direct inhalation occurs, cleanse lungs and respiratory passages with fresh air. In case of ingestion do not induce vomiting and seek medical attention immediately. If irritation or any other symptom attributable to exposure to this product persists, consult your physician.

CONTACT INFORMATION: To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Bimeda, Inc. at 1-888-524-6332. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or at www.fda.gov/reportanimalae

RESIDUE WARNING SECTION

Residue Warning: When used according to label directions, neither a pre-slaughter drug withdrawal period nor a milk discard time are required. Meat and milk from cattle treated with MoxiSolv Pour-On (moxidectin) may be used for human consumption at any time following treatment. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

OTHER SAFETY INFORMATION

OTHER WARNINGS

  • Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers.
  • Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance.
  • Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd/flock, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method).
  • A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

PRECAUTIONS SECTION

Precautions: For external use only. Do not apply to areas of skin with mange scabs, skin lesions, mud or manure. MoxiSolv Pour-On is not recommended for use in species other than cattle. This product has been formulated specifically for topical use in cattle and should not be used in other animal species or by other routes of administration as adverse reactions may occur.

MoxiSolv Pour-On is effective against the migrating stage of cattle grubs (Hypoderma larvae). Treatment with MoxiSolv Pour-On during the period when grubs are migrating through vital areas may cause undesirable host-parasite reactions. Killing H. lineatum when they are located in periesophageal tissues may cause bloat. Killing H. bovis when they are in the vertebral canal may cause staggering or hindlimb paralysis. Cattle should be treated as soon as possible after heel fly (warble fly) season to avoid this potential problem. Cattle treated with MoxiSolv Pour-On at the end of fly season can be re-treated during the winter without danger of grub-related reactions. Consult your veterinarian for more information regarding these secondary grub reactions and the correct time to treat with MoxiSolv Pour On.

ENVIRONMENTAL WARNING SECTION

Environmental Safety: Studies indicate that when moxidectin comes in contact with the soil it readily and tightly binds to the soil and becomes inactive. Free moxidectin may adversely affect fish and certain aquatic organisms. Do not contaminate water by direct application or by improper disposal of drug containers.

STORAGE AND HANDLING SECTION

Storage: Store at or below 25°C (77°F). Excursions to 40°C (104°F) are permitted. If product becomes frozen, thaw completely and shake well prior to use.

Disposal: Dispose of containers in an approved landfill or by incineration.

HOW SUPPLIED SECTION

Package Information: MoxiSolv Pour-On is available in two convenient container sizes. 169 fl oz/5 L and 338 fl oz/10 L conventional polyethylene containers are available for use with most commercially-available topical applicators.

SPL UNCLASSIFIED SECTION

Restricted Drug (CA) - Use Only As Directed

Approved by FDA under ANADA # 200-845

Rev 02/2026

Distributed by: MWI
Boise, ID 83705
www.VetOne.net

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

5L Front5L Front

5L Back5L Back

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
86136-14586136-145-22, 86136-145-17

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
MOXIDECTINNGU5H31YO9ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MoxidectinMOXIDECTINMedicines Development for Global Health6eb02ae9-9065-176f-e053-2991aa0ac8912026-07-30Warnings, Adverse reactionsName fallback
generic name: MOXIDECTIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.